Abstract
Systemic sclerosis (SSc) results from the complex interplay between the immune system, vasculature and tissue-repair mechanisms. Endothelial injury is the prime event; environmental triggers in the susceptible individual trigger the pathologic process, which translates into fibrosis. The outcome of SSc is not as bleak as it looked a couple of decades ago. With a greater understanding of older pathways, as well as elucidation of newer ones, the potential targets to block and even reverse fibrosis bring around a revolution in the way we look at this once dreaded disease.
| Original language | English |
|---|---|
| Pages (from-to) | S142-S148 |
| Journal | Indian Journal of Rheumatology |
| Volume | 12 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - 1 Nov 2017 |
Bibliographical note
Publisher Copyright:© 2017 Journal of Pediatric Neurosciences Published by Wolters Kluwer - Medknow.
Keywords
- Endothelial dysfunction
- endothelial progenitor cells
- endothelial to mesenchymal transition
- fibrosis
- hypoxia
- serotonin
- transforming growth factor-beta
ASJC Scopus subject areas
- Rheumatology
Fingerprint
Dive into the research topics of 'The pathogenesis of scleroderma'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver